EMV Capital PLC
LSE:EMVC

Watchlist Manager
EMV Capital PLC Logo
EMV Capital PLC
LSE:EMVC
Watchlist
Price: 55 GBX -0.9% Market Closed
Market Cap: £15.4m

EMV Capital PLC
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

EMV Capital PLC
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
EMV Capital PLC
LSE:EMVC
Research & Development
-£1.1m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
13%
Smith & Nephew PLC
LSE:SN
Research & Development
-$296m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Research & Development
-$185.8m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-16%
EKF Diagnostics Holdings PLC
LSE:EKF
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspiration Healthcare Group PLC
LSE:IHC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

EMV Capital PLC
Glance View

Market Cap
15.4m GBX
Industry
Health Care

NetScientific Plc is a deep tech and life sciences venture capital investment company. The firm identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. The company employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. The company secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The company develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The firm has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.

EMVC Intrinsic Value
10.73 GBX
Overvaluation 80%
Intrinsic Value
Price

See Also

What is EMV Capital PLC's Research & Development?
Research & Development
-1.1m GBP

Based on the financial report for Jun 30, 2025, EMV Capital PLC's Research & Development amounts to -1.1m GBP.

What is EMV Capital PLC's Research & Development growth rate?
Research & Development CAGR 10Y
13%

Over the last year, the Research & Development growth was 31%. The average annual Research & Development growth rates for EMV Capital PLC have been 9% over the past three years , 10% over the past five years , and 13% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett